Tel Aviv SMO
Tel Aviv, Israel
NCT Number: NCT05661136
It is unclear whether routine addition of intra-operative forced-air warming in addition to warmed intravenous fluids during cesarean delivery under spinal anesthesia is beneficial. In this single-center randomized trial, we aim to test the primary null hypothesis that our current protocol of warmed intravenous fluids is similar to a combination of warmed intravenous fluids with intra-operative lower-body forced-air warming to maintain maternal temperature after cesarean delivery under spinal anesthesia.
We also aim to assess the rate of maternal shivering during and after the procedure between the two groups, the maternal thermal comfort score, neonatal Apgar scores and umbilical pH levels. If we demonstrate no clinically important difference between the two interventions, clinicians will be able to continue our current protocol of warmed intravenous fluids only during cesarean delivery.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Not applicable
Tel Aviv, Israel
Primary aim Investigate whether a combination of intra-operative lower-body forced-air warming and warmed IV fluids is superior to our current standard of warmed IV fluids alone in influencing maternal core temperature following spinal anesthesia for cesarean delivery.
Secondary aim
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lower body blanket with warm air blower set at 44 deg c started after spinal anesthesia when patient placed in supine/left lat position
Control: Lower body blanket placed, not attached to warm air blower
Time frame: baseline, immediately before spinal anesthesia, 60 minutes following spinal anesthesia and then every 30 minutes for 2 hours (last measurement prior to discharge)
The primary aim is the mean core temperature on arrival to PACU. The means for the two groups will be compared.
Time frame: 60 minutes following spinal anesthesia
Maternal hypothermia yes/no defined as core body temperature <36°C
Time frame: Postoperative - every 30 minutes for 2 hours (last measurement prior to discharge)
Shivering score - 0 - no shivering
Time frame: baseline, immediately before spinal anesthesia , 60 minutes following spinal anesthesia, and then every 30 minutes for 2 hours (last measurement prior to discharge)
Maternal thermal comfort scores (• Thermal comfort scale - a 0 to 10 scale will be used with the descriptors to a single question - "How warm or cold are you?
o "Worst imaginable cold", " thermally neutral, " and " insufferably hot " representing the 0, 5, and 10 of the scale, respectively) will be obtained at baseline, 30 minutes during surgery, and on admission to PACU
Time frame: Postoperative - up to two hours during PACU recovery after the procedure
Meperidine administration (timing and dose) used to treat shivering
Time frame: 1 and 5 minutes after newborn delivery
Apgar scores (at 1 and 5 minutes) will be determined by the pediatrician (not involved in the study)
Time frame: Upon newborn's arrival to newborn ward - approximately 30 minutes following delivery
Newborn rectal temperature
Time frame: Immediately following placenta removal intraoperatively
venous blood gases will be obtained for analysis from a double-clamped segment of umbilical cord
Tel-Aviv Sourasky Medical Center
Other Gov
Maternal Postoperative Temperature After Cesarean Delivery Under Spinal Anesthesia With Warmed Intravenous Fluids: Randomized Controlled Trial With Versus Without Lower Body Forced Air Warming
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07728916
Body Temperature Changes, Pathological Conditions, Signs and Symptoms
Handan, Hebei, China
View Trial DetailsNCT07032493
Aging, Body Temperature Changes
Ottawa, Ontario, Canada
View Trial DetailsNCT05692947
Behavior, Body Temperature Changes
Eugene, Oregon, United States
View Trial DetailsNCT06853067
Body Temperature Changes, Pathological Conditions, Signs and Symptoms
Seoul, Select State/Province, South Korea
View Trial Details